165 related articles for article (PubMed ID: 10843470)
1. Descriptive epidemiology of endometrial hyperplasia in patients with abnormal uterine bleeding.
Anastasiadis PG; Skaphida PG; Koutlaki NG; Galazios GC; Tsikouras PN; Liberis VA
Eur J Gynaecol Oncol; 2000; 21(2):131-4. PubMed ID: 10843470
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathological analysis in cases with glandular and atypical glandular hyperplasia treated with gestagens].
Ivanov S
Akush Ginekol (Sofiia); 2005; 44(4):18-20. PubMed ID: 16028373
[TBL] [Abstract][Full Text] [Related]
3. Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women.
Wise MR; Gill P; Lensen S; Thompson JM; Farquhar CM
Am J Obstet Gynecol; 2016 Nov; 215(5):598.e1-598.e8. PubMed ID: 27287687
[TBL] [Abstract][Full Text] [Related]
4. Hysteroscopy with selective endometrial sampling after unsuccessful dilatation and curettage in diagnosis of symptomatic endometrial cancer and endometrial hyperplasias.
Spiewankiewicz B; Stelmachów J; Sawicki W; Kietlinska Z
Eur J Gynaecol Oncol; 1995; 16(1):26-9. PubMed ID: 7744113
[TBL] [Abstract][Full Text] [Related]
5. Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment.
Horn LC; Schnurrbusch U; Bilek K; Hentschel B; Einenkel J
Int J Gynecol Cancer; 2004; 14(2):348-53. PubMed ID: 15086736
[TBL] [Abstract][Full Text] [Related]
6. Clinico-epidemiological study of endometrial hyperplasia--a risk factor for the development of endometrial carcinoma?
Cărăuleanu A; Lupaşcu IA; Cărăuleanu DM; Socolov R; Socolov D
Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):154-61. PubMed ID: 25970959
[TBL] [Abstract][Full Text] [Related]
7. Endometrial cancer and hyperplasia rate in women before menopause with abnormal uterine bleeding undergoing endometrial sampling.
Gawron I; Łoboda M; Babczyk D; Ludwin I; Basta P; Pityński K; Ludwin A
Przegl Lek; 2017; 74(4):139-43.. PubMed ID: 29696944
[TBL] [Abstract][Full Text] [Related]
8. Relation of metabolic syndrome with endometrial pathologies in patients with abnormal uterine bleeding.
Özdemir S; Batmaz G; Ates S; Celik C; Incesu F; Peru C
Gynecol Endocrinol; 2015; 31(9):725-9. PubMed ID: 26182187
[TBL] [Abstract][Full Text] [Related]
9. Incidence of endometrial carcinoma in patients with endometrial hyperplasia.
Novac L; Grigore T; Cernea N; Niculescu M; Cotarcea S
Eur J Gynaecol Oncol; 2005; 26(5):561-3. PubMed ID: 16285581
[TBL] [Abstract][Full Text] [Related]
10. Premenopausal abnormal uterine bleeding and risk of endometrial cancer.
Pennant ME; Mehta R; Moody P; Hackett G; Prentice A; Sharp SJ; Lakshman R
BJOG; 2017 Feb; 124(3):404-411. PubMed ID: 27766759
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence and characteristics of endometrial polyps in patients with abnormal uterine bleeding].
Vojnosanit Pregl; 2008 May; 65(5):349-52. PubMed ID: 18630127
[TBL] [Abstract][Full Text] [Related]
13. The prognostic and therapeutic implications of cytologic atypia in patients with endometrial hyperplasia.
Hunter JE; Tritz DE; Howell MG; DePriest PD; Gallion HH; Andrews SJ; Buckley SB; Kryscio RJ; van Nagell JR
Gynecol Oncol; 1994 Oct; 55(1):66-71. PubMed ID: 7959270
[TBL] [Abstract][Full Text] [Related]
14. Endometrial polyps: prevalence, detection, and malignant potential in women with abnormal uterine bleeding.
Anastasiadis PG; Koutlaki NG; Skaphida PG; Galazios GC; Tsikouras PN; Liberis VA
Eur J Gynaecol Oncol; 2000; 21(2):180-3. PubMed ID: 10843481
[TBL] [Abstract][Full Text] [Related]
15. High rate of endometrial hyperplasia in renal transplanted women.
Bobrowska K; Kamiński P; Cyganek A; Pietrzak B; Jabiry-Zieniewicz Z; Durlik M; Paczek L
Transplant Proc; 2006; 38(1):177-9. PubMed ID: 16504696
[TBL] [Abstract][Full Text] [Related]
16. Could body mass index be an indicator for endometrial biopsy in premenopausal women with heavy menstrual bleeding?
Guraslan H; Dogan K; Kaya C; Senturk MB; Guraslan B; Helvacioglu C; Akbayir O; Yasar L
Arch Gynecol Obstet; 2016 Aug; 294(2):395-402. PubMed ID: 26895636
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with endometrial cancer and hyperplasia among middle-aged and older Hispanics.
Rodriguez AM; Polychronopoulou E; Hsu E; Shah R; Lamiman K; Kuo YF
Gynecol Oncol; 2021 Jan; 160(1):16-23. PubMed ID: 33221024
[TBL] [Abstract][Full Text] [Related]
18. Endometrial Biopsy in Low-Risk Women: Are We Over-Investigating?
Cartier S; Mayrand MH; Gougeon F; Simard-Émond L
J Obstet Gynaecol Can; 2022 Oct; 44(10):1097-1101. PubMed ID: 35753596
[TBL] [Abstract][Full Text] [Related]
19. Incidence of endometrial hyperplasia in 100 cases presenting with polymenorrhagia/menorrhagia in perimenupausal women.
Takreem A; Danish N; Razaq S
J Ayub Med Coll Abbottabad; 2009; 21(2):60-3. PubMed ID: 20524471
[TBL] [Abstract][Full Text] [Related]
20. Can ultrasound replace dilation and curettage? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer.
Gull B; Karlsson B; Milsom I; Granberg S
Am J Obstet Gynecol; 2003 Feb; 188(2):401-8. PubMed ID: 12592247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
